Whitehawk Therapeutics, Inc. - 10-Q Filing
Whitehawk Therapeutics filed a Form 10-Q for the quarter ended March 31, 2025. The filing includes details on financial instruments such as corporate debt securities and fair value measurements, along with information about equity incentive plans and milestone payments related to licensing agreements.
Tickers: $WHWK